PALI
PALISADE BIO, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.18
−0.84%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 131.82x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.69x
- Price / sales
- 411.28x
- Price / cash flow
- -11.31x
Enterprise value
- Enterprise value
- $80.5M
- EV / sales
- 160.94x
- EV / EBITDA
- -2.42x
- EV / EBIT
- -2.28x
- Market cap
- $205.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026